1.
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
by Sarwar, N
The Lancet (British edition), 2010, Vol.375 (9733), p.2215-2222
2.
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
by Voight, Benjamin F, PhD
The Lancet (British edition), 2012-08-11, Vol.380 (9841), p.572-580
3.
The Obesity Paradox, Cardiorespiratory Fitness, and Coronary Heart Disease
by McAuley, Paul A., PhD
Mayo Clinic proceedings, 2012, Vol.87 (5), p.443-451
4.
Dietary choline and betaine; associations with subclinical markers of cardiovascular disease risk and incidence of CVD, coronary heart disease and stroke: the Jackson Heart Study
by Millard, Heather R
European journal of nutrition, 2016-08-22, Vol.57 (1), p.51-60
5.
Independent Prognostic Value of High-sensitivity C-reactive Protein in Patients with Coronary Artery Ectasia
by Wang, Yintang
Chinese medical journal, 2016-11-01, Vol.129 (21), p.2582-2588
6.
Diagnostic value of scoring model of treadmill exercise test combined with dynamic electrocardiogram for latent coronary heart disease
by Wang, Wenrong
Journal of electrocardiology, 2021-11, Vol.69, p.82-86
7.
The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart dis...
by Athyros, V G
Journal of clinical pathology, 2004-07, Vol.57 (7), p.728-734
8.
A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk
by German, J.B
European journal of nutrition, 2009, Vol.48 (4), p.191-203
9.
Asthma and Proinflammatory Conditions: A Population-Based Retrospective Matched Cohort Study
by Yun, Hyun D., MD
Mayo Clinic proceedings, 2012, Vol.87 (10), p.953-960
10.
Serum Uric Acid Is a Determinant of Metabolic Syndrome in a Population-Based Study
by Onat, Altan
American journal of hypertension, 2006, Vol.19 (10), p.1055-1062
11.
Calculation of Coronary Angiographic Total Blush in Patients with Coronary Artery Disease and its Prognostic Implication
by Gai, Jing-Jing
Chinese medical journal, 2015, Vol.128 (18), p.2485-2490
12.
The French paradox: lessons for other countries
by FERRIERES, Jean
Heart (British Cardiac Society), 2004-01, Vol.90 (1), p.107-111
13.
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiov...
by Danesh, J
European journal of epidemiology, 2007-12-01, Vol.22 (12), p.839-869
14.
Risk factors for atrial fibrillation in type 2 diabetes: report from the Swedish National Diabetes Register (NDR)
by Zethelius, Björn
Diabetologia, 2015-06-19, Vol.58 (10), p.2259-2268
15.
Silent coronary heart disease in patients with type 2 diabetes: application of a screening approach in a follow-up study
by de Kreutzenberg, Saula Vigili
Journal of diabetes and its complications, 2017, Vol.31 (6), p.952-957
16.
Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: Design and baseline characteristics of the Alpha Omega Trial
by Geleijnse, Johanna M., PhD, FAHA
The American heart journal, 2010, Vol.159 (4), p.539-546.e2
17.
Newly diagnosed glucose intolerance and prognosis after acute myocardial infarction: comparison of post-challenge versus fasting glucose concentrations
by Tamita, Koichi
Heart (British Cardiac Society), 2012-06, Vol.98 (11), p.848-854
18.
Role of Circulating Fibrocytes in Cardiac Fibrosis
by Lin, Rong-Jie
Chinese medical journal, 2016, Vol.129 (3), p.326-331
19.
Meta-analysis for the Association of Apolipoprotein E ε2/ε3/ε4 Polymorphism with Coronary Heart Disease
by Zhang, Yong
Chinese medical journal, 2015, Vol.128 (10), p.1391-1398
20.
Effects of Percutaneous Coronary Intervention on Serum Angiopoietin-2 in Patients with Coronary Heart Disease
by Zeng, Zhi-Yu
Chinese medical journal, 2016, Vol.129 (6), p.631-635
